Zalcitabine
- 1 October 1992
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 44 (4), 656-683
- https://doi.org/10.2165/00003495-199244040-00009
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- In vitro toxicity and metabolism of 2′,3′-dideoxycytidine, an inhibitor of human immunodeficiency virus infectivityChemico-Biological Interactions, 1991
- Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infectionThe Journal of Pediatrics, 1990
- Cross-resistance to anti-HIV nucleoside analogs in multidrug-resistant human cellsBiochemical and Biophysical Research Communications, 1990
- The effect in vitro of 2'-deoxycytidine on the metabolism and cytotoxicity of 2',3'-dideoxycytidineAIDS, 1990
- 2′,3′-Didehydro-2′,3′-dideoxy-5-chlorocytidine is a selective anti-retrovirus agentBiochemical and Biophysical Research Communications, 1989
- Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related DideoxynucleosidesNew England Journal of Medicine, 1989
- Inhibition of bone marrow myelopoiesis and erythropoiesis in vitro by anti-retroviral nucleoside derivativesBritish Journal of Haematology, 1988
- Pharmacokinetics of 2‘,3’-Dideoxycytidine in Patients with AIDS and Related DisordersThe Journal of Clinical Pharmacology, 1988
- 2′ ,3′-dideoxynucleoside phosphorylation by deoxycytidine kinase from normal human thymus extracts: Activation of potential drugs for aids therapyBiochemical and Biophysical Research Communications, 1987
- Antiviral Therapy in AIDSDrugs, 1987